REFERENCE
MHRA.Human papillomavirus vaccine Cervarix: safety review shows balance of risks and benefits remains clearly positive. Drug Safety Update 6: H2, No. 4, 1 Nov 2012. Available from: URL: http://www.mhra.gov.uk
Rights and permissions
About this article
Cite this article
As of September 2012, the human papillomavirus (HPV) vaccine Gardasil replaced Cervarix in the UK’s national immunisation programme. React. Wkly. 1430, 3 (2012). https://doi.org/10.2165/00128415-201214300-00008
Published:
Issue Date:
DOI: https://doi.org/10.2165/00128415-201214300-00008